產(chǎn)品名稱 MAP3K8/Tpl2/COT Peptide from NOVUS BIOLOGICALS, LLC
    產(chǎn)品貨號(hào) NBP1-49679PEP
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
    產(chǎn)品規(guī)格 0.25 mg
    產(chǎn)品品牌 NOVUS BIOLOGICALS, LLC
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameMAP3K8/Tpl2/COT Peptide
    DescriptionSynthetic peptides corresponding to unique epitope on MAP3K8. The peptide sequence was selected from C-terminal-region, amimo acids 365-467. This peptide was covalently modified post-synthetically to achieve desired antigenicity.
    Size0.25 mg
    Concentrationn/a
    ApplicationsAntibody Competition
    Other NamesCancer Osaka thyroid oncogene, c-COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 2.7.11.25, ESTF, ESTFLJ10486, Ewing sarcoma transformant, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2
    Gene, Accession, CAS #MAP3K8, Gene ID: 1326, SwissProt: AAI13567
    Catalog #NBP1-49679PEP
    Price
    Order / More InfoMAP3K8/Tpl2/COT Peptide from NOVUS BIOLOGICALS, LLC
    Product Specific Referencesn/a
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>